ArticleSensors (Basel, Switzerland)2025
Voice-Based Assessment of Extrapyramidal Symptoms Using Deep Learning.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extrapyramidal symptoms encompass features of Parkinsonism, including bradykinesia, cogwheel rigidity, and resting tremors, which contribute to motor impairments hindering handwriting and speech. In this study, we analyzed voice data captured using a voice sensor setup from 94 patients exhibiting varying levels of EPS and 30 unaffected controls. Each participant provided 13 recordings of repeated vowel and consonant sounds. The Drug-Induced Extrapyramidal Side Effect Scale and Glasgow Antipsychotic Side Effect Scales were used when grading patients into mild, moderate, and severe extrapyramidal symptoms, both administered by trained clinicians. To develop an objective assessment tool, we employed a transfer learning approach using a DenseNet architecture for feature extraction and classification. Its architecture enables the hierarchical concatenation of features at each layer. In this study, we identified that key acoustic features, MFCC, chroma, and spectral contrast vary significantly with the severity of extrapyramidal symptoms. Based on these findings, we developed a DenseNet-based model capable of predicting extrapyramidal symptoms from voice data. This model can classify with an accuracy of 81.9% and a precision of 82.0%. To the best of our knowledge, this is the first study to introduce a voice-based model for assessing the severity of extrapyramidal symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.